Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Bladder Cancer

  Free Subscription


16.09.2019

1 Ann Surg Oncol
1 Anticancer Res
1 Arch Esp Urol
1 BMC Cancer
1 BMC Urol
1 Cancer Cell Int
1 Chem Commun (Camb)
1 Cochrane Database Syst Rev
1 Endocrinol Diabetes Nutr
1 Eur J Endocrinol
1 Eur Urol
1 Eur Urol Focus
1 Int Immunopharmacol
1 Int J Surg Pathol
2 Int J Urol
2 Investig Clin Urol
1 J Biosci
1 J Patient Rep Outcomes
2 J Urol
1 J Vet Intern Med
1 J Zoo Wildl Med
1 Math Biosci Eng
1 Med Sci Monit
1 Nat Rev Urol
1 Onco Targets Ther
1 Oncogene
1 Oncol Lett
1 Oncotarget
1 Pathol Oncol Res
1 Perm J
1 PLoS One
2 Surg Oncol
1 Turk J Urol
1 Urol Oncol
1 World J Surg Oncol


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Ann Surg Oncol

  1. DELL'OGLIO P, Tian Z, Leyh-Bannurah SR, Larcher A, et al
    Development of a New Comorbidity Assessment Tool for Specific Prediction of Perioperative Mortality in Contemporary Patients Treated with Radical Cystectomy.
    Ann Surg Oncol. 2019;26:1942-1949.
    PubMed     Text format     Abstract available


    Anticancer Res

  2. CHEN M, Tsai YT, Chang WS, Shih LC, et al
    Association of Caspase-8 Genotypes With Bladder Cancer Risk.
    Anticancer Res. 2019;39:4767-4773.
    PubMed     Text format     Abstract available


    Arch Esp Urol

  3. ARMAS-ALVAREZ AL, Fernandez-Lopez A, Donate-Moreno MJ, Salinas-Sanchez AS, et al
    [Bladder leiomyomas.]
    Arch Esp Urol. 2019;72:612-615.
    PubMed     Text format     Abstract available


    BMC Cancer

  4. YUK HD, Jeong CW, Kwak C, Kim HH, et al
    Clinical outcomes of muscle invasive bladder Cancer according to the BASQ classification.
    BMC Cancer. 2019;19:897.
    PubMed     Text format     Abstract available


    BMC Urol

  5. VAN HEMELRIJCK M, Sparano F, Josephs D, Sprangers M, et al
    Patient-reported outcomes in randomised clinical trials of bladder cancer: an updated systematic review.
    BMC Urol. 2019;19:86.
    PubMed     Text format     Abstract available


    Cancer Cell Int

  6. WANG L, Shi J, Huang Y, Liu S, et al
    A six-gene prognostic model predicts overall survival in bladder cancer patients.
    Cancer Cell Int. 2019;19:229.
    PubMed     Text format     Abstract available


    Chem Commun (Camb)

  7. DAI Z, Yang L, Li Y, Zhao C, et al
    A portable dual-mode sensor based on a TiO2 nanotube membrane for the evaluation of telomerase activity.
    Chem Commun (Camb). 2019;55:10571-10574.
    PubMed     Text format     Abstract available


    Cochrane Database Syst Rev

  8. HWANG EC, Sathianathen NJ, Imamura M, Kuntz GM, et al
    Extended versus standard lymph node dissection for urothelial carcinoma of the bladder in patients undergoing radical cystectomy.
    Cochrane Database Syst Rev. 2019;5:CD013336.
    PubMed     Text format     Abstract available


    Endocrinol Diabetes Nutr

  9. KIM JE, Martinez D
    Two uncommon cases of parathyroid hormone-related peptide mediated hypercalcemia in bladder carcinoma.
    Endocrinol Diabetes Nutr. 2019;66:69-70.
    PubMed     Text format    


    Eur J Endocrinol

  10. KO SH, Han K, Yun JS, Chung S, et al
    Impact of obesity and diabetes on the incidence of kidney and bladder cancers: a nationwide cohort study.
    Eur J Endocrinol. 2019 Sep 1. pii: EJE-19-0500.R2. doi: 10.1530/EJE-19-0500.
    PubMed     Text format     Abstract available


    Eur Urol

  11. SHI MJ, Meng XY, Chen CL, Dyrskjot L, et al
    Reply to Alexander Yang, Vincent L. Cannataro, Jeffrey P. Townsend's Letter to the Editor, re: Ming-Jun Shi, Xiang-Yu Meng, Philippe Lamy, et al. APOBEC-mediated Mutagenesis as, a Likely Cause of FGFR3 S249C Mutation Over-representation in Bladder Can
    Eur Urol. 2019 Sep 4. pii: S0302-2838(19)30656.
    PubMed     Text format    


    Eur Urol Focus

  12. WINOKER JS, Liaw CW, Galsky MD, Wiklund P, et al
    Clinical Complete Response after Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer: A Call for Standardized Assessments and Definitions.
    Eur Urol Focus. 2019 Sep 4. pii: S2405-4569(19)30227.
    PubMed     Text format     Abstract available


    Int Immunopharmacol

  13. SHARIFI L, Nowroozi MR, Amini E, Arami MK, et al
    A review on the role of M2 macrophages in bladder cancer; pathophysiology and targeting.
    Int Immunopharmacol. 2019;76:105880.
    PubMed     Text format     Abstract available


    Int J Surg Pathol

  14. NAYAK A, Depasquale B, Vergara N, Guzzo TA, et al
    Villous Adenoma Arising in the Native Bladder Mucosa and the Upper Urinary Tract With Coexisting Neuroendocrine Carcinoma Following Augmentation Cystoplasty.
    Int J Surg Pathol. 2019;27:450-456.
    PubMed     Text format     Abstract available


    Int J Urol

  15. CHOO SH, Nishiyama H, Kitamura H, Chen CH, et al
    Practice pattern of non-muscle invasive bladder cancer in Japan, Korea and Taiwan: A Web-based survey.
    Int J Urol. 2019 Sep 11. doi: 10.1111/iju.14105.
    PubMed     Text format     Abstract available

  16. NOHARA T, Kato Y, Nakano T, Nakagawa T, et al
    Intraoperative hypotension caused by oral administration of 5-aminolevulinic acid for photodynamic diagnosis in patients with bladder cancer.
    Int J Urol. 2019 Sep 11. doi: 10.1111/iju.14099.
    PubMed     Text format     Abstract available


    Investig Clin Urol

  17. PARK HS, Lee S, Lee J, Shin HB, et al
    Suppression of CD81 promotes bladder cancer cell invasion through increased matrix metalloproteinase expression via extracellular signal-regulated kinase phosphorylation.
    Investig Clin Urol. 2019;60:396-404.
    PubMed     Text format     Abstract available

  18. SAHIN Y, Yucetas U, Ates HA, Erkan E, et al
    Improving the diagnosis of high grade and stage bladder cancer by detecting increased urinary calprotectin expression in tumor tissue and tumor-associated inflammatory response.
    Investig Clin Urol. 2019;60:343-350.
    PubMed     Text format     Abstract available


    J Biosci

  19. WU X, Chen H, Zhang G, Wu J, et al
    MiR-212-3p inhibits cell proliferation and promotes apoptosis by targeting nuclear factor IA in bladder cancer.
    J Biosci. 2019;44.
    PubMed     Text format     Abstract available


    J Patient Rep Outcomes

  20. MICHELS CTJ, Wijburg CJ, Abma IL, Witjes JA, et al
    Translation and validation of two disease-specific patient-reported outcome measures (Bladder Cancer Index and FACT-Bl-Cys) in Dutch bladder cancer patients.
    J Patient Rep Outcomes. 2019;3:62.
    PubMed     Text format     Abstract available


    J Urol

  21. ATALA A
    Re: Bladder Cancer Extracellular Vesicles Drive Tumorigenesis by Inducing the Unfolded Protein Response in Endoplasmic Reticulum of Nonmalignant Cells.
    J Urol. 2019 Sep 12:10109701JU00005851520364998.
    PubMed     Text format    

  22. MOREY AF
    Re: Dual Prosthetic Implantation after Radical Cystoprostatectomy and Neobladder: Outcomes of the Inflatable Penile Prosthesis and Artificial Urinary Sphincter in Bladder Cancer Survivors.
    J Urol. 2019 Sep 13:101097JU0000000000000549. doi: 10.1097/JU.0000000000000549.
    PubMed     Text format    


    J Vet Intern Med

  23. LUETHCKE KR, Ekena J, Chun R, Trepanier LA, et al
    Glutathione S-transferase theta genotypes and environmental exposures in the risk of canine transitional cell carcinoma.
    J Vet Intern Med. 2019;33:1414-1422.
    PubMed     Text format     Abstract available


    J Zoo Wildl Med

  24. LINNEHAN B, Snyman H, DeLay J, Mareschal A, et al
    URINARY BLADDER TRANSITIONAL CELL CARCINOMA AND CARCINOMATOSIS IN A LINNAEUS'S TWO-TOED SLOTH, CHOLOEPUS DIDACTYLUS.
    J Zoo Wildl Med. 2019;50:278-281.
    PubMed     Text format     Abstract available


    Math Biosci Eng

  25. NAVE O, Hareli S, Elbaz M, Iluz IH, et al
    BCG and IL - 2 model for bladder cancer treatment with fast and slow dynamics based on SPVF method-stability analysis.
    Math Biosci Eng. 2019;16:5346-5379.
    PubMed     Text format     Abstract available


    Med Sci Monit

  26. LU J, Zhong F, Sun B, Wang C, et al
    Diagnostic Utility of Serum Golgi Phosphoprotein 3 in Bladder Cancer Patients.
    Med Sci Monit. 2019;25:6736-6741.
    PubMed     Text format     Abstract available


    Nat Rev Urol

  27. SCHNEIDER AK, Chevalier MF, Derre L
    The multifaceted immune regulation of bladder cancer.
    Nat Rev Urol. 2019 Sep 9. pii: 10.1038/s41585-019-0226.
    PubMed     Text format     Abstract available


    Onco Targets Ther

  28. MAN X, Liu T, Jiang Y, Zhang Z, et al
    Silencing of CARMA3 inhibits bladder cancer cell migration and invasion via deactivating beta-catenin signaling pathway.
    Onco Targets Ther. 2019;12:6309-6322.
    PubMed     Text format     Abstract available


    Oncogene

  29. CHEN J, Chou F, Yeh S, Ou Z, et al
    Androgen dihydrotestosterone (DHT) promotes the bladder cancer nuclear AR-negative cell invasion via a newly identified membrane androgen receptor (mAR-SLC39A9)-mediated Galphai protein/MAPK/MMP9 intracellular signaling.
    Oncogene. 2019 Sep 10. pii: 10.1038/s41388-019-0964.
    PubMed     Text format     Abstract available


    Oncol Lett

  30. PIGNOT G, Le Goux C, Vacher S, Schnitzler A, et al
    PLEKHS1: A new molecular marker predicting risk of progression of non-muscle-invasive bladder cancer.
    Oncol Lett. 2019;18:3471-3480.
    PubMed     Text format     Abstract available


    Oncotarget

  31. BOURN J, Pandey S, Uddin J, Marnett L, et al
    Detection of tyrosine kinase inhibitors-induced COX-2 expression in bladder cancer by fluorocoxib A.
    Oncotarget. 2019;10:5168-5180.
    PubMed     Text format     Abstract available


    Pathol Oncol Res

  32. SPACHMANN PJ, Azzolina V, Weber F, Evert M, et al
    Loss of CHEK2 Predicts Progression in Stage pT1 Non-Muscle-Invasive Bladder Cancer (NMIBC).
    Pathol Oncol Res. 2019 Sep 10. pii: 10.1007/s12253-019-00745.
    PubMed     Text format     Abstract available


    Perm J

  33. MCMULLEN CK, Rosetti MO, Weinmann S, Leo MC, et al
    Clinical Use Cases for a Tool to Assess Risk in Superficial Bladder Cancer.
    Perm J. 2019;23.
    PubMed     Text format     Abstract available


    PLoS One

  34. ZHU Z, Zhao J, Li Y, Pang C, et al
    Prognostic value of preoperative hydronephrosis in patients with bladder cancer undergoing radical cystectomy: A meta-analysis.
    PLoS One. 2019;14:e0222223.
    PubMed     Text format     Abstract available


    Surg Oncol

  35. CHOI SY, You D, Hong B, Hong JH, et al
    Impact of lymph node dissection in radical cystectomy for bladder cancer: How many vs how far?
    Surg Oncol. 2019;30:109-116.
    PubMed     Text format     Abstract available

  36. BAO Y, Liu X, Liu Y, Wang S, et al
    Ras-association domain family 1 (RASSF1A) gene regulates progression, migration and invasion of bladder cancer.
    Surg Oncol. 2019;30:63-71.
    PubMed     Text format     Abstract available


    Turk J Urol

  37. KAPOOR K, Datta C, Pal DK
    Is liquid-based cytology an alternative to conventional cytology for detection of malignant cells in urine of bladder cancer? Eastern Indian prospective observational study.
    Turk J Urol. 2019;45:351-356.
    PubMed     Text format     Abstract available


    Urol Oncol

  38. ROGGISCH J, Ecke T, Koch S
    Molecular identification of telomerase reverse transcriptase (TERT) promotor mutations in primary and recurrent tumors of invasive and noninvasive urothelial bladder cancer.
    Urol Oncol. 2019 Sep 11. pii: S1078-1439(19)30325.
    PubMed     Text format     Abstract available


    World J Surg Oncol

  39. WU L, Yang F, Song L, Xiao Z, et al
    Comparison of intracorporeal and extracorporeal urinary diversions after laparoscopic radical cystectomy in females with bladder cancer.
    World J Surg Oncol. 2019;17:161.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Bladder Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: